NOVARTIS AG filings

This page lists the SEC filings reported by NOVARTIS AG.

SEC filings by NOVARTIS AG ()
TypeFiled
6-K2022-10-25EDGAR
6-K2022-10-24EDGAR
6-K2022-09-21EDGAR
6-K2022-08-25EDGAR
6-K2022-07-19EDGAR
32022-06-27EDGAR
6-K2022-06-21EDGAR
SD2022-05-31EDGAR
20-F/A2022-04-26EDGAR
6-K2022-04-26EDGAR
6-K2022-04-04EDGAR
6-K2022-03-24EDGAR
SC 13G2022-02-04EDGAR
20-F2022-02-02EDGAR
6-K2022-02-02EDGAR
IRANNOTICE2022-02-02EDGAR
6-K2021-12-22EDGAR
6-K2021-12-20EDGAR
6-K2021-12-17EDGAR
6-K2021-11-04EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.